SEC Form 4 · accession 0001209191-15-022207
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W. Hesslein
Officer — SVP and General Counsel
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2015 | M | 10,934 | $4.16 | A | 71,059 | D | |
| Common Stock | Mar 2, 2015 | M | 3,125 | $7.12 | A | 74,184 | D | |
| Common StockF1 | Mar 2, 2015 | S | 1,424 | $48.35 | D | 72,760 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $4.16 | Mar 2, 2015 | M | 10,934 | D | — | Mar 7, 2023 | common stock | 10,934 | 14,066 | D |
| Stock Option (right to buy)F3 | $7.12 | Mar 2, 2015 | M | 3,125 | D | — | May 21, 2023 | common stock | 3,125 | 9,375 | D |
Explanation of responses
- F1The sale of these shares was made in a sell-to-cover transaction to cover the exercise price for the exercise of stock options.
- F2This option was granted on March 7, 2013 and vests in equal quarterly installments over a four-year period beginning on June 7, 2013.
- F3This option was granted on May 21, 2013 and vests in equal quarterly installments over a four-year period beginning on April 1, 2014.